Want to see LCTX full AI Analyst Report?
Lineage Therap (LCTX) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Opc1 | Spinal Cord Injury, Acute, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Spinal Cord Injury, Spinal Cord Injury, Chronic | Phase I | Recruiting | A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury | Feb 11, 2025 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Opc1 | Phase I | Spinal Cord Injury, Acute, Spinal Cord Injury Cervical, Spinal Cord Injury Thoracic, Spinal Cord Injury, Spinal Cord Injury, Chronic | Recruiting | A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury | Feb 11, 2025 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lineage Cell Therapeutics, Inc. (LCTX) have in its pipeline
Lineage Therap LCTX is currently developing the following drugs: Opc1. These drug candidates are in various stages of clinical development as the company works toward FDA approval.